SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
Salix Pharmaceuticals, Ltd.
---------------------------
(Name of Issuer)
Common Stock
------------
(Title of Class of Securities)
794906 3 05
------------------------------------------------
(CUSIP Number)
December 31, 1999
-----------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
- ------------------------
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
1. Name of Reporting Person
I.R.S. Identification No. of Above Person
Lorin K. Johnson
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(See Instructions)
(a) ____
Not Applicable (b) ____
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
United States
- --------------------------------------------------------------------------------
5. Sole Voting Power
Number of 789,000
Shares -----------------------------------------------------
Beneficially 6. Shared Voting Power
Owned By
Each Reporting
Person -----------------------------------------------------
7. Sole Dispositive Power
789,000
-----------------------------------------------------
8. Shared Dispositive Power
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each
Reporting Person
789,000
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
/ /
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
7.71%
- --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
<PAGE>
ITEM 1(A) NAME OF ISSUER
Salix Pharmaceuticals, Ltd.
ITEM 1(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
3600 W. Bayshore Road, Suite 205, Palo Alto, CA 94303
ITEM 2(A) NAME OF PERSON FILING
Lorin K. Johnson
ITEM 2(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE
3600 W. Bayshore Road, Suite 205, Palo Alto, CA 94303
ITEM 2(C) CITIZENSHIP
United States
ITEM 2(D) TITLE OF CLASS OF SECURITIES
Common Stock
ITEM 2(E) CUSIP NUMBER
794906 3 05
ITEM 3. FILING PURSUANT TO RULES 13D-1(B) OR 13D-2(B)
Not Applicable
ITEM 4. OWNERSHIP
(a) Amount beneficially owned:
At December 31, 1999 Mr. Johnson beneficially owned an
aggregate of 789,000 shares of the Issuer's common stock which
includes (i) options to purchase 29,000 shares of the Issuer's
common stock, that were exercisable within 60 days of December
31, 1999 and (ii) 674,500 shares of the Issuer's Common Stock
held by L and L Dantzker/Johnson Revocable Trust with respect
to which Mr. Johnson is the co-trustee and a beneficiary. In
addition, Mr. Johnson's wife is trustee of 37,860 shares held
by Johnson Grandchildren's Trust. Mr. Johnson disclaims
beneficial ownership of such shares.
(b) Percent of class:
1) 7.71%
<PAGE>
(c) Number of shares as to which such person has:
1) (i) Sole power to vote or to direct the vote: 789,000
(ii) Shared power to vote or to direct the vote:
(iii) Sole power to dispose or to direct the
disposition of: 789,000
(iv) Shared power to dispose or to direct the disposition
of:
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not Applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
Not Applicable
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February, 14, 2000
- --------------------------------------------
Date
/s/Lorin K. Johnson
- --------------------------------------------
Lorin K. Johnson
